Changes in Cancer Incidence, Deaths Expected by 2040
Most common cancers will be breast, melanoma, and lung, while most common cause of cancer-related death will remain lung
Breast Cancer
FDA Grants Full Approval to Trodelvy for Triple-Negative Breast Cancer
The treatment had previously been granted accelerated approval based on objective response rate and duration of response.
FDA: Complications Up for 2 Brands of Surgical Mesh Used in Breast Reconstruction
FlexHD and AlloMax brands lead to significantly higher rates of implant removal, reoperations, and infection within two years
US Breast Cancer Centers Recommend Earlier Initiation of Screening
Of the 431 centers that recommended a starting age, 87.2 percent gave recommendations different from those of national societies
Axillary Adenopathy Reported After Recent COVID-19 Vaccination
Management approach to these findings includes axillary ultrasound if clinical concern persists six weeks after final dose of vaccine
Aspirin Use May Improve Survival With Some Cancers
Investigators found no survival benefit among older patients with esophageal, gastric, pancreatic, or uterine cancer taking aspirin.
Potential Med Errors Prompt FDA Action on Vinca Alkaloid Labeling
Chemotherapy agents such as vincristine sulfate injection, vinblastine sulfate injection, and vinorelbine tartrate injection should only be prepared in IV infusion bags.
New Drugs Approved in 2020
Visit our New Drug Products page to stay up-to-date on the latest drug approvals.
Novel Breast Cancer Treatment Gains Approval
Phase 3 trial results showed that the objective response rate for margetuximab plus chemotherapy was 22% vs 16% for trastuzumab plus chemotherapy.
MPR Weekly Dose Podcast Episode 59
The latest on the vaccine development from Moderna, and BioNTech and Pfizer as they release more trial data; An at-home diagnostic test is approved; Keytruda gains expanded approval; And all the rest of the drug news from this past week.
